Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Abstract:

:Increasing evidence has shown that chemokine receptors may form functional dimers with unique pharmacological profiles. A common practice to characterize such G protein-coupled receptor dimerization processes is to apply bivalent ligands as chemical probes which can interact with both receptors simultaneously. Currently, two chemokine receptor dimers have been studied by applying bivalent compounds: the CXCR4-CXCR4 homodimer and the CCR5-MOR heterodimer. These bivalent compounds have revealed how dimerization influences receptor function and may lead to novel therapeutics. Future design of bivalent ligands for chemokine receptor dimers may be aided with the recently available CXCR4 homodimer, and CCR5 monomer crystal structures by more accurately simulating chemokine receptors and their dimers.

journal_name

Curr Top Med Chem

authors

Arnatt CK,Zhang Y

doi

10.2174/1568026614666140827144752

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

1606-18

issue

13

eissn

1568-0266

issn

1873-4294

pii

CTMC-EPUB-62042

journal_volume

14

pub_type

杂志文章,评审
  • Current Methods Applied to Biomaterials - Characterization Approaches, Safety Assessment and Biological International Standards.

    abstract::Safety and biocompatibility assessment of biomaterials are themes of constant concern as advanced materials enter the market as well as products manufactured by new techniques emerge. Within this context, this review provides an up-to-date approach on current methods for the characterization and safety assessment of b...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026618666180410151518

    authors: Oliveira JPR,Melendez-Ortiz HI,Bucio E,Alves PT,Lima MIS,Goulart LR,Mathor MB,Varca GHC,Lugao AB

    更新日期:2018-01-01 00:00:00

  • Carbonic anhydrase inhibitors as anticonvulsant agents.

    abstract::Seizures are one of the most common neurological disorders in clinical medicine. Triggering mechanisms by which seizures form remain unclear, but are related to a rapid change in ionic composition, including an increase of intracellular potassium concentration and pH shifts within the brain. pH buffering of extra- and...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802607780636726

    authors: Thiry A,Dogné JM,Supuran CT,Masereel B

    更新日期:2007-01-01 00:00:00

  • Can selective ligands for glutamate binding proteins be rationally designed?

    abstract::A major neurotransmitter, L-Glutamate must be stored, transported and received, and these processes are mediated by proteins that bind this simple yet essential amino acid. Detailed evidence continues to emerge on the structure of Glu binding proteins, which includes both receptors and transporters. It appears that re...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802606777057535

    authors: Natale NR,Magnusson KR,Nelson JK

    更新日期:2006-01-01 00:00:00

  • Strategies for the discovery and advancement of novel cationic antimicrobial peptides.

    abstract::Multi-drug resistant bacteria are appearing at an alarming rate and impose significant burdens on healthcare systems worldwide. Cationic peptides have shown great promise as broad spectrum antimicrobial agents with a demonstrated ability to kill resistant bacteria, however, issues such as protease susceptibility and t...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610793176648

    authors: Hadley EB,Hancock RE

    更新日期:2010-01-01 00:00:00

  • CYP17A1: a biochemistry, chemistry, and clinical review.

    abstract::Cytochrome P450 17A1 (CYP17A1; also P450c17and P450sccII) is a critically important enzyme in humans that catalyzes the formation of all endogenous androgens. It is an atypical cytochrome P450 enzyme in that it catalyzes two distinct types of substrate oxidation. Through its hydroxylase activity, it catalyzes the 17α-...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026611313120002

    authors: Porubek D

    更新日期:2013-01-01 00:00:00

  • Gamma-secretase modulation and its promise for Alzheimer's disease: a rationale for drug discovery.

    abstract::The genetics of Alzheimer's disease (AD) implies that restoring non-pathological levels or ratios of different amyloid-beta (Abeta) peptide species in the brain could prevent the onset or delay the progression of this neurodegenerative disease. In particular, a selective reduction of the longer Abeta(1-42) peptide whi...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802608783334051

    authors: Beher D

    更新日期:2008-01-01 00:00:00

  • Electrochemically driven supramolecular interaction of quinones and ferrocifens: an example of redox activation of bioactive compounds.

    abstract::This review discusses the state of the art, challenges and perspectives in recent applications of electrochemistry in the life sciences. It deals mainly with the elucidation of molecular mechanisms of drug action, drug design and development, involving electron transfer, pharmaco-electrochemistry (the combination of e...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: de Paiva YG,da Rocha Ferreira F,Silva TL,Labbe E,Buriez O,Amatore C,Fonseca Goulart MO

    更新日期:2015-01-01 00:00:00

  • The critical distance for the cycloaromatization reactions of enediynes.

    abstract::It has been shown that the enediyne anticancer antibiotics e.g., calicheamicin, neocarzinostatin and others cleave DNA via the putative intermediate 1,4-diradical formed in the Bergmann cyclization and are thus useful for cancer chemotherapy. The pharmacological activity of these drugs is based, in general, on the act...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/156802608783955719

    authors: Capitani JF,Gaffney SM,Castaldo L,Mitra A

    更新日期:2008-01-01 00:00:00

  • Peptidomimetic inhibitors of HIV protease.

    abstract::There are currently (July, 2002) six protease inhibitors approved for the treatment of HIV infection, each of which can be classified as peptidomimetic in structure. These agents, when used in combination with other antiretroviral agents, produce a sustained decrease in viral load, often to levels below the limits of ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043388330

    authors: Randolph JT,DeGoey DA

    更新日期:2004-01-01 00:00:00

  • Connecting small molecules to nuclear receptor pathways.

    abstract::Many efforts are currently being made to connect small molecules to target proteins by extracting pharmacological data from bibliographic sources and storing them in annotated chemical libraries. Here, small molecules are further connected to biological pathways, with particular focus to pathways involving members of ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/156802607782194671

    authors: Hettne K,Cases M,Boyer S,Mestres J

    更新日期:2007-01-01 00:00:00

  • Advances in the development of macrocyclic inhibitors of hepatitis C virus NS3-4A protease.

    abstract::Hepatitis C virus (HCV) is a major cause of acute hepatitis and chronic liver disease, including cirrhosis and hepatocellular carcinoma (HCC). No vaccine is currently available to prevent hepatitis C, and the current standard of care (SOC) - pegylated interferon-α (PEG-IFN-α) in combination with ribavirin (RBV) - is o...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610792232051

    authors: Avolio S,Summa V

    更新日期:2010-01-01 00:00:00

  • Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers.

    abstract::KRAS is the most common oncogene to be mutated in lung cancer, and therapeutics directly targeting KRAS have proven to be challenging. The mutations of KRAS are associated with poor prognosis, and resistance to both adjuvant therapy and targeted EGFR TKI. EGFR TKIs provide significant clinical benefit for patients who...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026619666190902150555

    authors: He H,Xu C,Cheng Z,Qian X,Zheng L

    更新日期:2019-01-01 00:00:00

  • Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.

    abstract::In 2010, the National Institutes of Health (NIH) established the Therapeutics for Rare and Neglected Diseases (TRND) program within the National Center for Advancing Translational Sciences (NCATS), which was created to stimulate drug discovery and development for rare and neglected tropical diseases through a collabor...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026613666131127160118

    authors: Ottinger EA,Kao ML,Carrillo-Carrasco N,Yanjanin N,Shankar RK,Janssen M,Brewster M,Scott I,Xu X,Cradock J,Terse P,Dehdashti SJ,Marugan J,Zheng W,Portilla L,Hubbs A,Pavan WJ,Heiss J,Vite CH,Walkley SU,Ory DS,Silbe

    更新日期:2014-01-01 00:00:00

  • In silico machine learning methods in drug development.

    abstract::Machine learning (ML) computational methods for predicting compounds with pharmacological activity, specific pharmacodynamic and ADMET (absorption, distribution, metabolism, excretion and toxicity) properties are being increasingly applied in drug discovery and evaluation. Recently, machine learning techniques such as...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026614666140929124203

    authors: Dobchev DA,Pillai GG,Karelson M

    更新日期:2014-01-01 00:00:00

  • Photoaffinity labeling in drug discovery and developments: chemical gateway for entering proteomic frontier.

    abstract::One of the major events occurring at biological interfaces is the specific recognition of bioactive ligands by their receptor proteins. The elucidation of interacting partners is an immediate entrance into the discovery of medicinal leads. The method of photoaffinity labeling enables the direct probing of target prote...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026023394182

    authors: Hatanaka Y,Sadakane Y

    更新日期:2002-03-01 00:00:00

  • Computer-Assisted Design of Thiophene-Indole Hybrids as Leishmanial Agents.

    abstract:BACKGROUND:Chemoinformatics has several applications in the field of drug design, helping to identify new compounds against a range of ailments. Among these are Leishmaniasis, effective treatments for which are currently limited. OBJECTIVE:To construct new indole 2-aminothiophene molecules using computational tools an...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026620666200616142120

    authors: Félix MB,de Araújo RSA,Barros RPC,de Simone CA,Rodrigues RRL,de Lima Nunes TA,da Franca Rodrigues KA,Junior FJBM,Muratov E,Scotti L,Scotti MT

    更新日期:2020-01-01 00:00:00

  • An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.

    abstract::One year after its first outbreak reported in China, coronavirus disease 2019 (COVID-19) pandemic is still sweeping the World causing serious infections and claiming more fatalities. COVID-19 is caused by the novel corona virus SARS-CoV-2, which belongs to the genus Betacoronavirus (β-CoVs) which is of greatest clinic...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026621666210119111409

    authors: Sabbah DA,Hajjo R,Bardaweel SK,Zhong HA

    更新日期:2021-01-18 00:00:00

  • Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species.

    abstract:BACKGROUND:Candida species are the important etiologic agents for candidiasis, the most prevalent cause of opportunistic fungal infections. Candida invasion results in mucosal to systemic infections through immune dysfunction and helps in further invasion and proliferation at several sites in the host. The host defence...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026619666191026105308

    authors: Wadhwa R,Pandey P,Gupta G,Aggarwal T,Kumar N,Mehta M,Satija S,Gulati M,Madan JR,Dureja H,Balusamy SR,Perumalsamy H,Maurya PK,Collet T,Tambuwala MM,Hansbro PM,Chellappan DK,Dua K

    更新日期:2019-01-01 00:00:00

  • Practical aspects of NMR-based fragment discovery.

    abstract::Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to the...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/156802607782341055

    authors: Zartler ER,Mo H

    更新日期:2007-01-01 00:00:00

  • Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

    abstract::Compared with the increasing and widespread bacterial resistance to clinical medicines and the urgent need for cures of intractable diseases, there is a dramatic decline in the numbers of drugs reaching the market or clinical trials. Accordingly, it has become imperative to discover more rational and efficient strateg...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026615666150825142002

    authors: Wang T,Wu MB,Zhang RH,Chen ZJ,Hua C,Lin JP,Yang LR

    更新日期:2016-01-01 00:00:00

  • Choline kinase active site provides features for designing versatile inhibitors.

    abstract::Choline kinase (CK) is a homodimeric enzyme that catalyses the transfer of the ATP γ-phosphate to choline, generating phosphocholine and ADP in the presence of magnesium. Several isoforms of CK are present in humans but only the HsCKα has been associated with cancer and validated as a drug target to treat this disease...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026614666141216093337

    authors: Serran-Aguilera L,Nuti R,López-Cara LC,Ríos-Marco P,Carrasco MP,Marco C,Entrena A,Macchiarulo A,Hurtado-Guerrero R

    更新日期:2014-01-01 00:00:00

  • Histone deacetylase inhibitors in cancer therapy: new compounds and clinical update of benzamide-type agents.

    abstract::Histone deacetylase (HDAC) inhibitors constitute a novel and growing class of anticancer agents that function by altering intracellular patterns of histone acetylation, the so-called epigenetic "histone code," thereby producing changes in cell cycle arrest, differentiation, and/or apoptosis in tumor cells. This overvi...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802608784911581

    authors: Moradei O,Vaisburg A,Martell RE

    更新日期:2008-01-01 00:00:00

  • Elucidating Treatment of Alzheimer's Disease via Different Receptors.

    abstract::Alzheimer's disease (AD) is an irreversible multifaceted neurodegenerative disorder that gradually degrades neuronal cells. Presently, it is the most common reason for the memory loss and dementia in older individuals. It is patho-physiologically described by extracellular amyloid beta (Aβ) deposition, intracellular n...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026617666170103163715

    authors: Ul Islam B,Khan MS,Jabir NR,Kamal MA,Tabrez S

    更新日期:2017-01-01 00:00:00

  • Structure-based analysis of the molecular recognitions between HIV-1 TAR-RNA and transcription factor nuclear factor-kappaB (NFkB).

    abstract::In this paper we applied the "macromolecular docking" procedure to perform molecular modeling with the aim of screening transcription factor sequences for possible interaction to the HIV-1 TAR-RNA, employing the software Hex version 4.2. The molecular modeling data were compared with electrophoretic mobility shift ass...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802612800166800

    authors: Khan MT,Mischiati C,Ather A,Ohyama T,Dedachi K,Borgatti M,Kurita N,Gambari R

    更新日期:2012-01-01 00:00:00

  • Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.

    abstract::Alpha-particles are of considerable growing interest for Targeted Alpha Therapy (TAT). TAT gains more attention as new targets, chemical labeling techniques and α-particle emitters are developed but translation of TAT into the clinic has been slow, in part because of the limited availability and the short physical hal...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026611212230002

    authors: Huclier-Markai S,Alliot C,Varmenot N,Cutler CS,Barbet J

    更新日期:2012-01-01 00:00:00

  • CORAL: classification model for predictions of anti-sarcoma activity.

    abstract::A modified version of the CORAL software (http://www.insilico.eu/coral) allows building up the classification model for the case of the Yes/No data on the anti-sarcoma activity of organic compounds. Three random splits into the sub-training, calibration, and test sets of the data for 3017 compounds were examined. The ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026611212240004

    authors: Toropov AA,Toropova AP,Benfenati E,Gini G,Leszczynska D,Leszczynski J

    更新日期:2012-01-01 00:00:00

  • Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases.

    abstract::The H(3) histamine receptor is expressed in many brain regions, including those involved in sleep/wake regulation and cognitive functions. Inhibition of the H(3) receptor leads to increased release of multiple neurotransmitters in these regions, making this receptor an ideal target for the potential enhancement of aro...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610790411027

    authors: Raddatz R,Tao M,Hudkins RL

    更新日期:2010-01-01 00:00:00

  • Structure-based Methods for Binding Mode and Binding Affinity Prediction for Peptide-MHC Complexes.

    abstract::Understanding the mechanisms involved in the activation of an immune response is essential to many fields in human health, including vaccine development and personalized cancer immunotherapy. A central step in the activation of the adaptive immune response is the recognition, by T-cell lymphocytes, of peptides display...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026619666181224101744

    authors: Antunes DA,Abella JR,Devaurs D,Rigo MM,Kavraki LE

    更新日期:2018-01-01 00:00:00

  • Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Di-hydropyridine Analogs as Potent Antioxidants.

    abstract:AIM:The aim of this study is to synthesize, characterize and biological evaluation of 3-ethyl 5- methyl2-(2-aminoethoxy)-4-(2-chlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate derivatives. BACKGROUND:An efficient synthesis of two series of novel carbamate and sulfonamide derivatives of amlodipine, 3-ethyl 5-methyl 2...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026619666191105100959

    authors: Sudhana SM,Adi PJ

    更新日期:2019-01-01 00:00:00

  • PNP anticancer gene therapy.

    abstract::Escherichia coli purine nucleoside phosphorylase (PNP) catalyzes the cleavage of 9-(2-deoxy-beta-D-ribofuranosyl)-6-methylpurine (MeP-dR), while human PNP does not. MeP-dR is well tolerated while the cleavage product, 6-methylpurine (MeP), is highly cytotoxic. This clinical profile suggests an anticancer gene therapy ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802605774463105

    authors: Zhang Y,Parker WB,Sorscher EJ,Ealick SE

    更新日期:2005-01-01 00:00:00